The Small Business and Technology Development Center's Bill Rollinson will provide practical methods for motivating your team and boosting retention—without stretching your budget. In this interactive ...
Atlantic Fish, an emerging Raleigh company developing cultivated seafood, has received a $50,000 SEED grant from North Carolina IDEA, a private foundation supporting the state’s entrepreneurial ...
Amgen’s decision to locate – and now expand – in Holly Springs fortifies the town’s and state’s reputations as ...
Enhancing soil health is “one of those rare win-win situations,” Wayne Honeycutt, president and CEO of the Morrisville, NC-based Soil Health Institute told the 2018 Ag Biotech Summit. “It’s good for ...
NeuroTronik Inc. of Durham has closed on $23.1 million in Series B preferred stock financing to advance its therapy for treating acute heart failure in hospitals. The Durham-based venture capital firm ...
The North Carolina Biotechnology Center is pleased to welcome our newest Landing Pad tenant, Todd DeZwaan of LemnaTec. Headquartered in Aachen, Germany, LemnaTec has led the global development of ...
Join Women in Bio's RTP Chapter on December 10 for its End-of-Year Celebration—a special evening for women to connect, celebrate achievements, and enjoy meaningful networking. Additionally, Pepper ...
Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.
If you’re a visionary leader at a growth stage biopharma company, I help you identify a calculated and informed path to scale — one that mitigates risk, maximizes value, and capitalizes on your ...